Blue Jet Healthcare Ltd reported a weaker March 2026 quarter performance, with revenue, profitability and operating margins declining sharply on a year-on-year basis.
Revenue from operations for Q4FY26 stood at ₹234.67 crore, compared with ₹340.45 crore reported in the corresponding quarter last year, reflecting a decline of around 31% YoY.
The company’s profit after tax came in at ₹64.34 crore during the quarter, down from ₹110.01 crore reported in Q4FY25.
Operational performance also weakened significantly during the period. Based on the reported financials, EBITDA for Q4FY26 stood at ₹71.27 crore compared with ₹139.97 crore in the year-ago quarter. EBITDA margin contracted sharply to 30.4% from 41.1% in Q4FY25, indicating a compression of nearly 1,070 basis points.
Total income during the quarter stood at ₹257.59 crore against ₹352.67 crore in the corresponding quarter last year.
Among key expense heads, cost of materials consumed stood at ₹92.89 crore during the quarter, while employee benefit expenses came in at ₹18.48 crore. Other expenses were reported at ₹42.72 crore.
Finance costs for the quarter stood at ₹0.58 crore, while depreciation and amortisation expenses came in at ₹6.46 crore.
The company’s board has also approved raising of funds up to the tune of Rs 1,000 crore by the way of issuance of equity or other related instruments.
For the full financial year FY26, the company reported revenue from operations of ₹947.32 crore compared with ₹1,029.99 crore in FY25. Profit after tax for the year stood at ₹247.82 crore against ₹305.20 crore reported in the previous financial year.
Disclaimer: This article is based on company filings and publicly available financial disclosures. Investors are advised to consult certified financial advisors before making investment decisions.